• Paper

    Kazunori Kataoka, Project Professor

Developing a nanomachine which associates with nucleic acid pharmaceuticals in a rendezvous like manner in vivo to target brain tumors

A research group of Kazunori KATAOKA (Project Professor, Institute for Future Initiatives / Director General, iCONM) and Kanjiro MIYATA (Associate Professor, Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo) and, Yutaka KONDO (Professor, Nagoya University Graduate School of Medicine) , succeeded in developing the Nucleic Acid Medicine-loaded Nanomachine, a technology that can stably protect nucleic acid drugs that are prone to deactivation in the bloodstream and deliver them to intractable cancers such as pancreatic cancer and brain tumors.

The results of this research were published in “Nature Communications” on Apr. 24.


Kazunori Kataoka
Project Professor, Institute for Future Initiatives